Turk J Med Sci. 2019 Feb 11;49(1):198-205. doi: 10.3906/sag-1802-137.
BACKGROUND/AIM: Widespread use of antiretroviral treatment (ART) has led to decrease in the incidence of HIV/AIDS-related mortality. Besides the availability of ART, medication adherence is essential for treatment success. There is a scarcity of data reported from Turkey regarding ART adherence among people living with HIV/AIDS (PLWHA). Therefore, this study was undertaken to determine medication adherence and related factors among PLWHA in Turkey. MATERIALS AND METHODS: The sample consisted of 158 PLWHA, who were being followed up at Infectious Diseases Outpatient Clinic of Hacettepe University Hospital. Data were collected using an individual questionnaire and the Turkish version of the Morisky Medication Adherence Scale. RESULTS: The median patient age was 38 years, 80.4% were male, and 51.3% were married. The median duration of both HIV infection and ART was 3 years. Sixty-one percent used two drug regimens. Sixty-one percent were highly adherent to ART while 37.9% were moderately adherent. The absence/presence of social support resources, disease duration, ART duration, and being informed about the ART regimen were statistically associated with medication adherence. CONCLUSION: Our results suggest that medication adherence is excellent among Turkish PLWHA. Interventions, including effective social support, and continuous counseling about ART, might further boost the adherence of PLWHA
背景/目的:抗逆转录病毒治疗(ART)的广泛应用导致了与 HIV/AIDS 相关的死亡率的下降。除了 ART 的可及性之外,药物依从性对于治疗成功至关重要。关于土耳其 HIV/AIDS 感染者(PLWHA)的 ART 依从性,报告的数据稀缺。因此,本研究旨在确定土耳其 PLWHA 的药物依从性及其相关因素。
材料和方法:该样本由 158 名正在哈塞特佩大学医院传染病门诊接受随访的 PLWHA 组成。数据通过个人问卷和土耳其版 Morisky 药物依从性量表收集。
结果:患者的中位年龄为 38 岁,80.4%为男性,51.3%已婚。HIV 感染和 ART 的中位持续时间均为 3 年。61%使用两种药物方案。61%的患者对 ART 高度依从,而 37.9%的患者中度依从。社会支持资源的有无、疾病持续时间、ART 持续时间以及是否了解 ART 方案与药物依从性呈统计学相关。
结论:我们的结果表明,土耳其 PLWHA 的药物依从性非常好。包括有效社会支持和持续关于 ART 的咨询在内的干预措施可能会进一步提高 PLWHA 的依从性。
J Infect Dev Ctries. 2012-11-26
Appl Health Econ Health Policy. 2015-2
AIDS Res Hum Retroviruses. 2015-9
J Int AIDS Soc. 2013-10-8
Int J Environ Res Public Health. 2021-2-4
Turk J Med Sci. 2020-12-17
Rev Gaucha Enferm. 2017-4-20
Curr Opin Virol. 2016-3-28
Int J Infect Dis. 2016-3